Home » Topics » BioWorld Science

BioWorld Science
RSS

AWD-140-190: new anticonvulsant with favorable efficacy and safety profile

Sep. 5, 1997

Warner-Lambert/CoCensys disclose subtype-selective NMDA antagonists

Sep. 5, 1997

Antimitotic cryptophycin compounds

Sep. 5, 1997

Warner-Lambert reports novel MMP inhibitors

Sep. 5, 1997

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

Celgene claims PDE/TNF/NFkappaB inhibitors

Sep. 5, 1997

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

SmithKline Beecham synthesizes mechanism-based HSV protease inhibitors

Sep. 5, 1997

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

Summary of azelnidipine preclinical data

Sep. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...